Literature DB >> 6347486

Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high-parasitemia and cerebral malaria.

P Brasseur, M Agrapart, J J Ballet, P Druilhe, M J Warrell, S Tharavanij.   

Abstract

Several cell-mediated functions were studied in vivo and in vitro in 63 Thai patients with acute falciparum malaria, including 21 cases with cerebral manifestations and 10 cases with initial parasitemia over 10%. Initial delayed cutaneous reactions to phytohemagglutinin and soluble protein antigens were negative in most cerebral malaria cases. In other patients, skin reactions were impaired or abolished as a direct function of parasitemia. No major alteration in the numbers of blood T and B lymphocytes was found. In lymphocyte cultures, proliferative responses to lectins were generally found within normal ranges; in contrast, proliferative responses to candidin were suppressed in parallel with delayed cutaneous responses to the same antigen. From these data, it can be concluded that the alteration of specific cell-mediated responses are predominantly detectable in acute cases with major parasite invasion, i.e., high parasitemia and/or cerebral manifestations. A direct role of Plasmodium falciparum was further suggested by the rapid restoration of cell-mediated functions observed in several cases under successful antimalarial therapy. These results do not support any evidence in favor of a preexisting cellular immune deficiency in relation with the occurrence of cerebral or high-parasitemia acute malaria in these patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347486     DOI: 10.1016/0090-1229(83)90054-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  17 in total

1.  HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls.

Authors:  Kirsten E Lyke; Robin B Burges; Yacouba Cissoko; Lansana Sangare; Abdoulaye Kone; Modibo Dao; Issa Diarra; Marcelo A Fernández-Vina; Christopher V Plowe; Ogobara K Doumbo; Marcelo B Sztein
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen, CD54, and CD11c in human monocytes.

Authors:  E Schwarzer; M Alessio; D Ulliers; P Arese
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

3.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Prognostic value of anti-Plasmodium falciparum-specific immunoglobulin G3, cytokines, and their soluble receptors in West African patients with severe malaria.

Authors:  J L Sarthou; G Angel; G Aribot; C Rogier; A Dieye; A Toure Balde; B Diatta; P Seignot; C Roussilhon
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals.

Authors:  Y A Abu-Zeid; T G Theander; N H Abdulhadi; L Hviid; B O Saeed; S Jepsen; J B Jensen; R A Bayoumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

6.  Impairment of Plasmodium falciparum-specific antibody response in severe malaria.

Authors:  P Brasseur; J J Ballet; P Druilhe
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

7.  Regulation of the immune response in Plasmodium falciparum malaria: IV. T cell dependent production of immunoglobulin and anti-P. falciparum antibodies in vitro.

Authors:  L Kabilan; M Troye-Blomberg; M E Patarroyo; A Björkman; P Perlmann
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

8.  Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria.

Authors:  E M Riley; G Andersson; L N Otoo; S Jepsen; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

9.  Soluble plasma IL-2 receptors and malaria.

Authors:  E M Riley; P Rowe; S J Allen; B M Greenwood
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

10.  A Plasmodium yoelii soluble factor inhibits the phenotypic maturation of dendritic cells.

Authors:  Jamie M Orengo; Kurt A Wong; Carlos Ocaña-Morgner; Ana Rodriguez
Journal:  Malar J       Date:  2008-12-15       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.